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Abstract
Background: Undescended testis, or cryptorchidism, occurs in 2–5% of boys born at term, and by 12 months of age about
1% of all boys have manifest cryptorchidism. Several hormonal substances control this process and disruption of the foetal
sex-hormones balance is a potential cause of undescended testis, however, to a great extent the aetiology of cryptorchidism
is unclear.
Methodology: To study risk factors involved in the aetiology of undescended testis, we assessed cancer risk in 15,885
mothers of men operated for undescended testis in Sweden. Women were followed-up for a median period of 23 years
during which 811 first primary malignancies occurred. Their cancer incidence was compared with that in the general
population estimating standardized incidence ratio (SIR) and corresponding 95% confidence interval (CI).
Principal Findings: The overall cancer risk experienced by the mothers of cryptorchid men did not differ significantly from
that of the general population (SIR = 0.94; 95% C.I. = 0.88–1.01). Specifically, there was a reduction in ovarian cancer risk
(SIR = 0.72; 95% C.I. = 0.51–0.99), while the risk of lung (SIR = 1.38 95% C.I. 1.03–1.81) and biliary tract/liver cancer (SIR: 1.76,
95% CI: 1.03–2.82) were increased.
Conclusions: Although we cannot rule out the role of chance, our data suggest a positive association between
undescended testis and maternal lung cancer and a negative association with ovarian cancer, where the first may be partly
attributable to smoking and the second to an altered hormonal milieu during pregnancy and thus both exposures may be
risk factors for cryptorchidism.
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Introduction
Undescended testis, or cryptorchidism, occurs in 2–5% of boys
born at term [1]. Testes that are undescended at birth may
descend spontaneously during early life, but by 12 months of age
about 1% of all boys have manifest cryptorchidism [1,2].
During male foetal development, the testes descend into the
scrotum in two phases, the transabdominal followed by the
inguinoscrotal phase. Several hormonal substances control this
process, but androgens are known to be instrumental in the
second phase of testis descent [3]. It has therefore been
suggested that disruption of the foetal sex-hormones balance is
a potential cause of undescended testis. Prematurity and low
birth weights are associated with an increased prevalence of
cryptorchidism [4,5,6], as well as placental dysfunction and
maternal smoking have been indicated as other potential risk
factors [6,7,8]. To a great extent, however, the aetiology of
cryptorchidism is unclear.
To find further clues on possible risk factors involved in the
aetiology of undescended testis, we have analyzed maternal cancer
risk as a proxy to foetal exposure in a large cohort of cryptorchid
men.
Results
The cohort consisted of 15885 women followed-up for a median
period of 23 years (range: 0–36 years), during which 811 first
primary malignancies, 29 second-primary malignancies and 1
third-primary malignancy occurred. The main characteristics of
the cohort are summarised in Table 1.
The overall cancer risk experienced by the mothers of
cryptorchid men did not differ significantly from that of the
general population (SIR= 0.94; 95% C.I. = 0.88–1.01) (Table 2).
Specifically, there was an increased risk of biliary tract/liver
(SIR= 1.76 95% C.I. 1.03–2.82) and lung (SIR= 1.38 95%
C.I. 1.03–1.81) cancers and a reduction in ovarian cancer risk
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(SIR=0.72; 95% C.I. = 0.51–0.99). None of the associations was
substantially modified by age at diagnosis (Table 3) or the
exclusion of the mothers of men born before 1970 (SIR of biliary
tract/liver cancer: 1.86, 95% CI: 0.89–3.43; SIR of lung cancer:
1.38, 95% C.I. 0.94–1.95 cancers; SIR of ovarian cancer: 0.73,
95% C.I. 0.47–1.08).
Discussion
In this cohort study, we found that mothers of men operated for
undescended testis have an increased risk of developing cancer of
the biliary tract/liver and lung, and a decreased risk of developing
ovarian cancer.
We used strict criteria for the identification of men with
cryptorchidism (based both on diagnosis and surgical procedure),
thus maximizing specificity of the exposure status. In addition, the
use of highly complete nation-wide registries enabled the
identification of 99% of the mothers and a complete follow-up.
It should be noted, however, that since we analysed the risk of
several different cancer sites (n = 19) some of our results might be
explained by chance alone. Moreover, the comparison of the
cancer incidence between the mothers of cryptorchid men and the
general Swedish population is biased by the fact that only the latter
includes nulliparous women. If women with children have, on
average, different health status, lifestyle and socio-economic
conditions than nulliparous women, this biased comparison may
alter the finding of no overall difference in cancer risk among
mothers of cryptorchid men. In addition, the bias may affect our
results on breast and ovarian cancer, which are both inversely
associated with number of children [9,10]. However, while the risk
was slightly decreased for breast cancer it was strongly reduced for
ovarian cancer, suggesting that the results on ovarian cancer are
not entirely explained by this source of bias. Indeed the bias
Table 1. Characteristics of the cohort of mothers of
cryptorchid boys.
Characteristic
Nu of subjects
(N=15885) Person-years
Age (years)
18–24 5432 132356
25–29 3679 127231
30–34 3306 69662
35–39 1230 25781
40–44 228 4869
45–49 10 229
Calendar period
1965–1969 2767 89599
1970–1974 3572 98907
1975–1979 3444 79606
1980–1984 2935 53597
1985–1989 2206 30048
1990–1994 900 8047
1995+ 61 323
doi:10.1371/journal.pone.0014285.t001
Table 2. Standardized incidence ratios (SIRs), and corresponding 95% confidence intervals (CI) of cancer among mothers of
cryptorchid boys.
Cancer site ICD-7 Code Obs. Exp. SIR 95% CI
All sites 140–209,
excl. 191
811 859.69 0.94 (0.88–1.01)
Oral cavity, pharynx 140–148
excl. 142,146
5 7.74 0.65 (0.21–1.51)
Stomach 151 6 11.54 0.52 (0.19–1.13)
Colon-rectum 153, 154 43 53.76 0.80 (0.58–1.08)
Biliary tract, liver 155 17 9.66 1.76 (1.03–2.82)
Pancreas 157 6 10.24 0.59 (0.21–1.28)
Lung 162 52 37.60 1.38 (1.03–1.81)
Breast 170 325 335.14 0.97 (0.87–1.08)
Cervix uteri 171 48 53.78 0.89 (0.66–1.18)
Corpus uteri 172 38 38.12 1.00 (0.71–1.37)
Ovary 175 38 52.75 0.72 (0.51–0.99)
Kidney 180 19 12.87 1.48 (0.89–2.31)
Urinary organs 181 8 11.32 0.71 (0.31–1.39)
Skin malignant melanoma 190 63 56.99 1.10 (0.85–1.41)
Nervous system 193 38 43.17 0.88 (0.62–1.21)
Thyroid gland 194 16 18.90 0.85 (0.48–1.37)
Endocrine glands 195 23 25.51 0.90 (0.57–1.35)
Non-Hodgkin’s lymphoma 200 20 19.19 1.04 (0.64–1.61)
Leukemias 204 14 16.30 0.86 (0.47–1.44)
Unspecified Sites 199 17 18.60 0.91 (0.53–1.46)
Note: SIR: Standardized Incidence Ratio; CI: Confidence Interval; Obs.: Observed; Exp.: Expected.
doi:10.1371/journal.pone.0014285.t002
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resulting by the inclusion of childless women in the reference
population is expected to be rather limited. For example, assuming
that i) 10% of the women in the Swedish population remain
childless, ii) these women have a 40% increased risk of breast
cancer and iii) the risk of breast cancer is the same among mothers
of cryptorchid boys and the general population, our study would
find an SIR 0.98 (instead of 1.0) due to the bias introduced by
parity.
The pathogenesis of ovarian cancer is largely unknown. It
appears to be strongly influenced by hormonal factors [11], as for
instance, hormonal replacement therapy has been associated with
an increased risk of ovarian cancer [12], while contraceptive
therapy and multi-parity are documented protective factors
against this cancer [11]. As sex hormones levels during pregnancy
are also implicated in the aetiology of cryptorchidism [13] our
finding of a 30% reduction in risk of ovarian cancer among
mothers of men with cryptorchidism is intriguing. Recently,
among term deliveries, a strong protective effect of low birth
weight on the maternal risk of epithelial ovarian cancer has been
found, whereas birth weight seemed to have little effect on the risk
of ovarian cancer among preterm births [14,15]. This association
was interpreted as a sign of altered hormonal milieu during
pregnancy. Interestingly these factors, namely hormonal patterns
during pregnancy, prematurity and low birth weight have all been
linked to crytporchidism [6,16].
Our finding of an increased risk of lung cancer in mothers of
cryptorchid men may be explained by shared risk factors, since
maternal smoking during pregnancy has been reported to be
associated with an increased risk of cryptorchidism in some studies
[5,6,8], although not all [16,17]. However, apart from lung
cancer, we did not find among the mothers of cryptorchid boys
increased risks of other smoking-related cancers, such as head and
neck cancer and bladder cancer. Interestingly, maternal lung
cancer has been associated also with the risk of testicular cancer in
a number of studies [18,19,20] but maternal smoking has been
repeatedly found not to be associated with testicular cancer risk
[21]. Yet unidentified mechanisms should thus explain the link
between lung cancer in mothers and testicular cancer in sons [22]
and similar mechanisms could also have a role in explaining the
association between maternal lung cancer and cryptorchidism.
The increased risk of cancer of the liver/biliary tract that we
found was unexpected and in the lack of an a priori hypothesis and
a plausible post hoc-explanation, we consider chance as the most
likely explanation.
In conclusion, our data suggest a positive association between
undescended testis and maternal lung cancer that may be partly
attributable to smoking. The inverse association between cryptor-
chidism and maternal ovarian cancer merits replication, as it is
consistent with potential risk factors for cryptorchidism, including
an altered maternal hormonal milieu during pregnancy.
Methods
The study population was identified through a linkage of several
Swedish data sources using the national registration number
(NRN). All Swedish residents alive in 1947 onward have been
assigned a 10-digit NRN, which is a unique personal identifier
referred to in all medical records and official registers. Through
the use of the NRN, it is possible to link information from several
databases together.
Since 1958 in Sweden, physicians as well as pathologists, or
cytologists, who confirm them, must report all newly diagnosed
malignant tumours to the National Cancer Registry (The
National Board of Health and Welfare, Swedish Cancer Registry:
http://www.social-styrelsen.se/en/Statistics/statsbysubject/Cancer+
Registry.htm). Completeness of cancer registration is estimated above
95% [23].
In 2000, Statistics Sweden began a linkage between the several
data sources from the national registration and created the
Swedish Multi-Generation Register, which contains information
on the parents of all individuals in Sweden born in 1932 onward
and survived until 1961. Adoption or other non-biologic relations
are flagged in the register [24].
We have previously described the cohort of men operated at
different ages for cryptorchidism, assembled using the Swedish
Hospital Discharge Register [25]. By linking this cohort of men
(n= 17396 for the present study) to the Swedish Multi-Generation
Register, we identified their mothers. The linkage was 99%
complete (250 missing), resulting in a cohort of 16864 mothers
(272 mothers had two cryptorchid sons and 5 mothers had 3
cryptorchid sons). Information on migration obtained from the
Registry of Population and Population Changes was used to
exclude 747 women who were not resident in Sweden when they
delivered their son. Finally, we excluded 232 women aged less
than 18 at the time of delivery from the cohort, leaving 15,885
women for analysis.
The mothers were followed-up from the date of delivery of their
cryptorchid son to the date of emigration, death, or December 31,
2000, whichever occurred first. Information on cancer incidence
was obtained from the Swedish Cancer Registry. Coding of
multiple primary cancers followed a common set of rules proposed
by the International Association of Cancer Registries and the
IARC [26]. According to these rules, a primary cancer is one that
originates in a primary site or tissue and is thus not an extension, a
recurrence, or a metastasis.
For all malignancies combined (excluding non-melanoma skin
cancers) and for each cancer site with at least 10 observed cases,
we calculated the standardized incidence ratio (SIR) comparing
the number of observed cases with the number of expected cases
on the basis of the 5-year age and period-specific rates in the
Swedish population. We estimated 95% confidence intervals (C.I.)
Table 3. Age-specific standardized incidence ratios (SIRs) and
95% confidence intervals (CIs) of biliary tract/liver, lung and
ovarian cancer among mothers of cryptorchid boys.
Age groups (years)* Observed SIR 95% CI
Biliary tract/liver cancer
,45 4 1.99 (0.54–5.10)
45–54 7 1.68 (0.68–3.46)
55+ 6 1.72 (0.63–3.75)
Lung cancer
,50 22 1.47 (0.92–2.22)
50–59 19 1.12 (0.68–1.75)
60+ 11 1.93 (0.96–3.46)
Ovarian cancer
,45 14 0.71 (0.39–1.20)
45–54 16 0.69 (0.40–1.13)
55+ 8 0.79 (0.34–1.56)
*Due to a different age-distribution in incidence age cut-offs differed for lung
cancer.
doi:10.1371/journal.pone.0014285.t003
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assuming a Poisson distribution and carried out the analyses using
the software STATAH, version 9.
For cancer sites associated with a statistically significant SIR, we
carried out further analyses stratifying by attained age. We also
checked the effect of the incomplete coverage of the Swedish
population by the Hospital Discharge Register by sensitivity
analysis excluding 2767 mothers of boys born before 1970, when
the Register was less complete.
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